Rubicon (RBCN) (RHHBY) (TPX) (TRV) (WPI) (AXS) Upgraded

Rubicon Technology, Inc. (NASDAQ: RBCN), Roche Holding Ltd. (NASDAQ: RHHBY), Tempur-Pedic International Inc. (NYSE: TPX), The Travelers Companies, Inc. (NYSE: TRV), Watson Pharmaceuticals Incorporated (NYSE: WPI) and Axis Capital (NYSE: AXS) were upgraded by analysts.

Rubicon Technology, Inc. (RBCN) was upgraded by RBC Capital from an “Underperform” rating to a “Neutral” rating. They have a price target of $9.00 on the company.

Roche Holding Ltd. (RHHBY) was upgraded by Sanford C. Bernstein from a “Market Perform” rating to an “Outperform” rating.

Tempur-Pedic International Inc. (TPX) was upgraded by Oppenheimer from a “Perform” rating to an “Outperform” rating. They have a price target of $70.00 on the company.

The Travelers Companies, Inc. (TRV) was upgraded by Sandler O’Neill from a “Hold” rating to a “Buy” rating.

Watson Pharmaceuticals Incorporated (WPI) was upgraded by CLSA from an “Outperform” rating to a “Buy” rating.

Axis Capital (AXS) was upgraded by Keefe, Bruyette & Woods to an “Outperform” rating.

Rubicon (RBCN) (IFF) (MMYT) (ROVI) (MRX) (AH) Ratings, Price Targets

Rubicon Technology, Inc. (NASDAQ: RBCN), International Flavors & Fragrances Inc. (NYSE: IFF), Makemytrip Limited (NASDAQ: MMYT), Rovi Corp. (NASDAQ: ROVI), Medicis Pharmaceuticals (NYSE: MRX) and Accretive Health, Inc. (NYSE: AH) ratings and price target changes and reiterations.

Rubicon Technology, Inc. (RBCN) was downgraded by Avian from a “Positive” rating to a “Neutral” rating.

International Flavors & Fragrances Inc. (IFF) had its price target lowered by RBC Capital from $63.00 to $56.00. They have a “Sector Perform” rating on the company.

Makemytrip Limited (MMYT) had its price target raised by Maxim Group from $25.00 to $39.00. They have a “Buy” rating on the company.

Rovi Corp. (ROVI) had its price target lowered by Canaccord Genuity from $71.00 to $63.00. They have a “Buy” rating on the company.

Medicis Pharmaceuticals (MRX) had its price target lowered by Piper Jaffray (NYSE:PJC) to $43.00.

Oppenheimer reiterated its "Market Perform" rating on Accretive Health, Inc. (AH).

Rubicon (RBCN) (CREE) (PDS) (EDMC) (OTIV) (HLS) (NKTR) Get New Coverage

Rubicon Technology, Inc. (NASDAQ: RBCN), Cree, Inc. (NASDAQ: CREE), Precision Drilling (NYSE: PDS), Education Management Corp (NASDAQ: EDMC), On Track Innovations Ltd (NASDAQ: OTIV), HealthSouth (NYSE: HLS) and Nektar Therapeutics (NASDAQ: NKTR) getting new analyst coverage.

Ticonderoga initiated coverage on Rubicon Technology, Inc. (RBCN). They placed a “Sell” rating and a price target of $9.00 on the company.

Ticonderoga initiated coverage on Cree, Inc. (CREE). They placed a “Buy” rating and a price target of $39.00 on the company.

Howard Weil initiated coverage on Precision Drilling (PDS). They placed an “Outperform” rating and a price target of $17.00 on the company.

Wunderlich initiated coverage on Education Management Corp. (EDMC). They placed a “Buy” rating and a price target of $20.00 on the company.

Merriman Curhan Ford initiated coverage on On Track Innovations Ltd (OTIV). They placed a “Neutral” rating on the company.

Mizuho initiated coverage on HealthSouth (HLS). They placed a “Buy” rating on the company.

MKM Partners initiated coverage on Nektar Therapeutics (NKTR). They placed a “Buy” rating and a price target of $12.00 on the company.

TECO (TE) (RBCN) (AVB) (CLP) (HGG) (KFT) Price Targets Changed

TECO Energy, Inc. (NYSE: TE), Rubicon Technology, Inc. (NASDAQ: RBCN), AvalonBay Communities, Inc. (NYSE: AVB), Colonial Properties (NYSE: CLP), HHGregg (NYSE: HGG) and Kraft Foods (NASDAQ: KFT) price targets adjusted by analysts.

TECO Energy, Inc. (TE) had its price target lowered by UBS AG (NYSE:UBS) to $19.00. They have a “Buy” rating on the company. They cited valuation as the catalyst behind the call.

Rubicon Technology, Inc. (RBCN) had its price target lowered by UBS AG from $28.00 to $15.00. They have a “Buy” rating on the company.

AvalonBay Communities, Inc. (NYSE: AVB) had its price target raised by analysts at FBR Capital from $142.00 to $146.50. The analysts now have an “outperform” rating on the company.

Colonial Properties (NYSE: CLP) had its price target raised by analysts at FBR Capital from $23.00 to $24.50. The analysts now have an “outperform” rating on the company.

HHGregg (NYSE: HGG) had its price target lowered by analysts at UBS AG from $15.00 to $12.00. The analysts now have a “neutral” rating on the company.

Kraft Foods (NASDAQ: KFT) had its price target raised by analysts at Stifel Nicolaus from $37.00 to $39.00. The analysts now have a “buy” rating on the company.

Price Targets (NRG) (PEG) (PKI) (RBCN) (SLXP) Updated

Price Targets on NRG Energy, Inc. (NYSE: NRG), Public Service Enterprise Group Inc. (NYSE: PEG), PerkinElmer, Inc. (NYSE: PKI), Rubicon Technology, Inc. (NASDAQ: RBCN) and Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) were updated by analysts.

Barclays Capital raised their price target on NRG Energy, Inc. (NRG) from $19.00 to $22.00. They have an “equal weight” rating on the company.

Barclays Capital raised their price target on Public Service Enterprise Group Inc. (PEG) from $31.00 to $33.00. They have an “equal weight” rating on the company.

Deutsche Bank (NYSE:DB) raised their price target on PerkinElmer, Inc. (PKI) from $30.00 to $35.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Rubicon Technology, Inc. (RBCN) from $38.00 to $40.00. They have a “buy” rating on the company.

UBS AG raised their price target on Salix Pharmaceuticals, Ltd. (SLXP) from $37.00 to $39.00. They have a “neutral” rating on the company.

Biggest Losers (GTLS) (MFLX) (GSIT) (RBCN) (THM) on May 6

Among the big, negative movers on Friday, May 6, were Chart Industries (GTLS), Multi-Fineline Electronix (MFLX), GSI Technology (GSIT), Rubicon Technology (RBCN) and Team Health Holdings (THM).

Chart Industries (GTLS) was down $2.04, to close at $46.34, a loss of 4.22 percent.

Multi-Fineline Electronix (MFLX) fell $1.90 on the day to close at $22.47, a loss of 7.80 percent.

GSI Technology (GSIT) dropped $1.83 to close at $6.50, a loss of 21.97 percent.

Phillips-Van Heusen (PVH) declined $1.83 to close the session at $25.87, a loss of 6.61 percent.

Team Health Holdings (THM) plunged $1.74 to end the day at $20.75, a loss of 7.74 percent.

Cree (NASDAQ:CREE), Rubicon Technology (NASDAQ:RBCN), AIXTRON (NASDAQ:AIXG), Veeco (NASDAQ:VECO) And Chinese Policy

It appears the Chinese may be changing their policy strategy for energy and power, and may push subsidies from upstream manufacturing toward downstream segments, which would have an impact on Cree (NASDAQ:CREE), Rubicon Technology (NASDAQ:RBCN), AIXTRON (NASDAQ:AIXG) and Veeco (NASDAQ:VECO), among others.

Canaccord said, "We are providing an update on the LED space following some recent noise, rumors and what we perceive as overall confusion in the space regarding the subsidy situation in China. For months now, our view is and has been that the Chinese Central Government is not pulling its subsidies but instead on the verge of a policy change, as part of the 12th 5-year plan to move government funds from upstream manufacturing subsidies toward downstream demand-based subsidies. We view this change as a long-term positive for the LED ecosystem as a whole, including volume LED component pure plays such as Cree (HOLD), Epistar, Formosa Epitaxy and material volume plays such as Rubicon Technology (BUY). In the near term, we also acknowledge the volatility this may cause for the incumbent tool suppliers AIXTRON (HOLD) and Veeco (HOLD) given the current Street expectations and general view that these companies are secular and not cyclical – which is not our view."

"We believe that there still remains a fundamental disconnect between Street expectations of equipment and likely shipments. As such, we feel stock valuations have run up beyond the supporting fundamentals. Given the increase in expectations over past year and the dependence on China to meet these expectations, the subsidy change could serve as a negative catalyst for the upstream tool suppliers. To be clear: we believe 2010 will represent a historical peak for MOCVD orders. Given the share appreciation on misinformation regarding the scale and scope of the Second Cycle and timing of the Third Cycle, we would not be averse to investors using both incumbent MOCVD suppliers as a short-term source of funds – even after recent pullbacks."

Cree, Inc. was trading at $66.48, down $0.78, or 1.16 percent, as of 12:05 PM EST. Rubicon Technology was at $20.01, down $0.33, or 1.62 percent. Aixtron was trading at $33.13, losing $0.82, or 2.42 percent. Veeco was at $40.53, dropping $1.23, or 2.95 percent.